Rebound of Multiple Sclerosis Disease Activity After Switching from Fingolimod or Natalizumab to Cladribine Tablets: Real World Experience from the Arabian Gulf
- Resource Type
- Abstract
- Source
- In
Multiple Sclerosis and Related Disorders December 2023 80 - Subject
- Language
- ISSN
- 2211-0348